What is Chardan Capital Markets's price target for PRQR?

Chardan Capital Markets's latest stated price target for ProQR Therapeutics N.V. (PRQR) is $2, from its action on Nov 8, 2023.

What is Chardan Capital Markets's rating on PRQR?

Chardan Capital Markets rates PRQR Buy, a bullish rating, as of Nov 8, 2023.

When did Chardan Capital Markets last change its view on PRQR?

On Nov 8, 2023, Chardan Capital Markets upgrades to Buy from Neutral, price target $2.

Analyst firms · Chardan Capital Markets · PRQR

Chardan Capital Markets PRQR price target and rating history

ProQR Therapeutics N.V. (PRQR) · Health Care

Chardan Capital Markets rates ProQR Therapeutics N.V. (PRQR) Buy with a $2 price target, as of its latest action on Nov 8, 2023. It has published 3 rating actions on PRQR since August 2021, including 1 upgrade and 0 downgrades.

Current rating: Buy
Price target: $2
Median target, all firms: Too few
Actions on PRQR: 3

Chardan Capital Markets price target on PRQR

Chardan Capital Markets price target on PRQR, each point a stated target, August 2021 to November 2023.

Every Chardan Capital Markets rating on PRQR

Nov 8, 2023
UpgradeChardan Capital Markets upgrades to Buy from Neutral, price target $2
Feb 14, 2022
ReiterateChardan Capital Markets cuts its price target to $8 from $18, keeps Buy
Aug 9, 2021
ReiterateChardan Capital Markets cuts its price target to $18 from $20, keeps Buy

How other firms rate PRQR

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
BofA Securities	Buy	$8	Aug 20, 2026
Oppenheimer	Outperform	$9	Mar 12, 2026

Questions about Chardan Capital Markets and PRQR

What is Chardan Capital Markets's price target for PRQR?: Chardan Capital Markets's latest stated price target for ProQR Therapeutics N.V. (PRQR) is $2, from its action on Nov 8, 2023.
What is Chardan Capital Markets's rating on PRQR?: Chardan Capital Markets rates PRQR Buy, a bullish rating, as of Nov 8, 2023.
When did Chardan Capital Markets last change its view on PRQR?: On Nov 8, 2023, Chardan Capital Markets upgrades to Buy from Neutral, price target $2.

More PRQR rating histories

Raymond James4

All Chardan Capital Markets ratings PRQR news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.